AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma
Blood Cancer Talks
The Importance of Comparative Efficacy in Early Relapse Patients
The real world data, I think, can also help us in this regard. Would you reserve CAR-T only for high-risk patients or those with aggressive relapse? It's a great question and one that I probably am still working through myself. And then once we get more survival data and more data on these non-relaps mortality, second malignancies, et cetera, if we're more comfortable that that's not eating in too much to the survival picture, there will be going to be using it for a lot more patients.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode